Expanded Activated Lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Expanded Activated Lymphocytes, covering 2022-02-07 to 2022-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection [Phase 2]